keyword
MENU ▼
Read by QxMD icon Read
search

Fecal lactoferrin

keyword
https://www.readbyqxmd.com/read/28442839/the-place-of-calprotectin-lactoferrin-and-high-mobility-group-box-1-protein-on-diagnosis-of-acute-appendicitis-with-children
#1
Sevgi Buyukbese Sarsu, Ayse Binnur Erbagci, Hasan Ulusal, Suleyman Cuneyt Karakus, Özlem Gümüstekin Bulbul
The purpose of this study is to investigate the role of serum calprotectin (CP), lactoferrin (LF), and high-mobility group protein B1 (HMGB-1) levels and fecal CP and LF levels in differential diagnosis of acute uncomplicated appendicitis from other causes of abdominal pain and further from complicated appendicitis. Totally, 120 children were included grouped into 4 as: healthy controls, patients with right lower quadrant pain with other than surgical causes, patients with uncomplicated appendicitis, and patients with complicated appendicitis...
April 2017: Indian Journal of Surgery
https://www.readbyqxmd.com/read/28318585/lactoferrin-reduces-mortality-in-preweaned-calves-with-diarrhea
#2
RANDOMIZED CONTROLLED TRIAL
G Habing, K Harris, G M Schuenemann, J M Piñeiro, J Lakritz, X Alcaraz Clavijo
Calf diarrhea is the most common reason for mortality and antimicrobial therapy in preweaned calves on dairy farms in the United States. Conventional and organic livestock producers require alternative therapies for calf diarrhea to reduce the necessity of conventional antimicrobials. Alternatives administered for mild cases or early in the disease course may be useful to mitigate disease progression and reduce the likelihood of septicemia and negative sequelae. Lactoferrin is a bioactive protein naturally found in colostrum that has been shown to prevent septicemia in high-risk infants...
May 2017: Journal of Dairy Science
https://www.readbyqxmd.com/read/28217373/update-on-clinical-and-research-application-of-fecal-biomarkers-for-gastrointestinal-diseases
#3
REVIEW
Imran Siddiqui, Hafsa Majid, Shahab Abid
Gastrointestinal (GI) diseases comprise a large spectrum of clinical conditions ranging from indigestion to inflammatory bowel diseases (IBDs) and carcinomas. Endoscopy is the usual method employed to diagnose these condition. Another noninvasive way to assess and diagnose GI conditions are fecal biomarkers. Fecal biomarkers provide information regarding a specific disease process and are perhaps more acceptable to clinicians and patients alike because of their non-invasivity compared to endoscopy. Aim of this review was to evaluate the current status of the fecal biomarkers in clinical and research for in GI diseases...
February 6, 2017: World Journal of Gastrointestinal Pharmacology and Therapeutics
https://www.readbyqxmd.com/read/28216085/occurrence-of-clostridium-difficile-ribotype-027-in-hospitals-of-silesia-poland
#4
Małgorzata Aptekorz, Anna Szczegielniak, Barbara Wiechuła, Celine Harmanus, Ed Kuijper, Gayane Martirosian
Clostridium difficile is an important healthcare-associated pathogen, responsible for a broad spectrum of diarrheal diseases. The aim of this prospective study was to determine the occurrence of C. difficile infection (CDI), to characterize cultured C. difficile strains and to investigate the association of fecal lactoferrin with CDI. Between January 2013 and June 2014, 148 stool samples were obtained from adult diarrheal patients (C. difficile as a suspected pathogen) hospitalized in different healthcare facilities of 15 Silesian hospitals...
February 12, 2017: Anaerobe
https://www.readbyqxmd.com/read/28172842/p307-fecal-lactoferrin-levels-are-stable-during-pregnancy
#5
B Koslowsky, D M Livovsky, E Goldin, A Bar-Gil Shitrit
No abstract text is available yet for this article.
February 1, 2017: Journal of Crohn's & Colitis
https://www.readbyqxmd.com/read/28165288/lactoferrin-interacts-with-bile-acids-and-increases-fecal-cholesterol-excretion-in-rats
#6
Kanae Nakamura, Satoru Morishita, Tomoji Ono, Michiaki Murakoshi, Keikichi Sugiyama, Hisanori Kato, Ikuo Ikeda, Hoyoku Nishino
Lactoferrin (LF) is a multifunctional cationic protein (pI 8.2-8.9) in mammalian milk. We previously reported that enteric-LF prevented hypercholesterolemia and atherosclerosis in a diet-induced atherosclerosis model using Microminipig, although the underlying mechanisms remain unclear. Because LF is assumed to electrostatically interact with bile acids to inhibit intestinal cholesterol absorption, LF could promote cholesterol excretion. In this study, we assessed the interaction between LF and taurocholate in vitro, and the effect of LF on cholesterol excretion in rats...
February 2017: Biochemistry and Cell Biology, Biochimie et Biologie Cellulaire
https://www.readbyqxmd.com/read/28030847/swimming-attenuates-inflammation-oxidative-stress-and-apoptosis-in-a-rat-model-of-dextran-sulfate-sodium-induced-chronic-colitis
#7
Ling Qin, Zhi-Qiang Yao, Qi Chang, Ya-Li Zhao, Ning-Ning Liu, Xiao-Shan Zhu, Qin-Qin Liu, Li-Feng Wang, An-Gang Yang, Chun-Fang Gao, Jun-Tang Li
Increasing evidence suggests that regular physical exercise suppresses chronic inflammation. However, the potential inhibitory effects of swimming on dextran sulfate sodium (DSS)-induced chronic colitis, and its underlying mechanisms, remain unclear. In this study, rats were orally administered DSS to induce chronic colitis, and subsequently treated with or without swimming exercise. A 7-week swimming program (1 or 1.5 hours per day, 5 days per week) ameliorated DSS-caused colon shortening, colon barrier disruption, spleen enlargement, serum LDH release, and reduction of body weight gain...
January 31, 2017: Oncotarget
https://www.readbyqxmd.com/read/27977555/recurrent-clostridium-difficile-infection-in-children-patient-risk-factors-and-markers-of-intestinal-inflammation
#8
Maribeth R Nicholson, Jonathan D Crews, Jeffrey R Starke, Zhi-Dong Jiang, Herbert DuPont, Kathryn Edwards
BACKGROUND: The management of Clostridium difficile infection (CDI) in children is complicated by recurrence rates of 20%-30%. The identification of risk factors associated with recurrent disease might allow early recognition of those children at highest risk. METHODS: Pediatric patients with CDI were identified through clinical laboratory records at 2 tertiary-care children's hospitals from March 2013 through May 2014. Subjects were enrolled and followed for 60 days to assess for recurrent CDI (rCDI)...
April 2017: Pediatric Infectious Disease Journal
https://www.readbyqxmd.com/read/27821031/does-helicobacter-pylori-eradication-therapy-trigger-or-protect-against-crohn-s-disease
#9
REVIEW
H As Murad
Helicobacter pylori (H. pylori) infection is involved in multiple gastrointestinal and extra-gastrointestinal disorders. This review focuses on possible link between H. pylori eradication and Crohn's disease (CD) which is a chronic inflammatory bowel disease (IBD). Fecal calprotectin and; to lesser extent; fecal lactoferrin are sensitive and specific markers for monitoring CD activity. Data about link between H. pylori eradication and CD are limited and inconclusive. The infection likely shifts equilibrium between T helper 1 (Th1) and Th2 immune responses to the Th2 pattern...
July 2016: Acta Gastro-enterologica Belgica
https://www.readbyqxmd.com/read/27801789/administration-of-a-multi-strain-probiotic-product-to-women-in-the-perinatal-period-differentially-affects-the-breast-milk-cytokine-profile-and-may-have-beneficial-effects-on-neonatal-gastrointestinal-functional-symptoms-a-randomized-clinical-trial
#10
RANDOMIZED CONTROLLED TRIAL
Maria Elisabetta Baldassarre, Antonio Di Mauro, Paola Mastromarino, Margherita Fanelli, Domenico Martinelli, Flavia Urbano, Daniela Capobianco, Nicola Laforgia
BACKGROUND: Probiotic supplementation to women during pregnancy and lactation can modulate breast milk composition, with immune benefits being transferred to their infants. AIM: The aim of the study was to evaluate the effect of high-dose probiotic supplementation to women during late pregnancy and lactation on cytokine profile and secretory IgA (sIgA) in breast milk and thus to study if differences in breast milk composition can affect lactoferrin and sIgA levels in stool samples of newborns...
October 27, 2016: Nutrients
https://www.readbyqxmd.com/read/27746954/comparisons-between-myeloperoxidase-lactoferrin-calprotectin-and-lipocalin-2-as-fecal-biomarkers-of-intestinal-inflammation-in-malnourished-children
#11
Mara de Moura Gondim Prata, A Havt, D T Bolick, R Pinkerton, Aam Lima, R L Guerrant
Fecal biomarkers have emerged as important tools to assess intestinal inflammation and enteropathy. The aim of this study was to investigate the correlations between the fecal markers, myeloperoxidase (MPO), lactoferrin (FL), calprotectin (FC) and lipocalin-2 (Lcn-2), and to compare differences by breastfeeding status as well as normalization by fecal protein or by fecal weight. Simultaneous, quantitative MPO, FL, FC and Lcn-2, levels were determined in frozen fecal specimens collected from 78 children (mean age 15...
2016: Journal of Translational Science
https://www.readbyqxmd.com/read/27693318/accuracies-of-fecal-calprotectin-lactoferrin-m2-pyruvate-kinase-neopterin-and-zonulin-to-predict-the-response-to-infliximab-in-ulcerative-colitis
#12
Anne-Claire Frin, Jérôme Filippi, Gilles Boschetti, Bernard Flourie, Jocelyne Drai, Patricia Ferrari, Xavier Hebuterne, Stéphane Nancey
BACKGROUND: Fecal markers might predict the response to anti-TNFα in ulcerative colitis (UC). AIMS: To compare the performance of fecal calprotectin (fCal), lactoferrin (fLact), M2-PK (fM2-PK), neopterin (fNeo), and zonulin (fZon) to predict the response to therapy in active UC patients. METHODS: Disease activity from 31 consecutive patients with an active UC, treated with infliximab (IFX) was assessed by the Mayo score at baseline and at week 14 and by the partial Mayo score at W52 and stool samples collected for fecal marker measurements at W0, W2, and W14...
January 2017: Digestive and Liver Disease
https://www.readbyqxmd.com/read/27253661/pediatric-crohn-disease-clinical-outcome-assessments-and-biomarkers-current-state-and-path-forward-for-global-collaboration
#13
Haihao Sun, Richard Vesely, Kerry Jo Lee, Agnes Klein, Mutsuhiro Ikima, Andrew E Mulberg
OBJECTIVE: There is a pressing need for drug development in pediatric Crohn disease (CD). Our aim was to provide strategic approaches toward harmonization of current thinking about clinical outcome assessments (COAs) and biomarkers to facilitate drug development in pediatric CD. METHODS: Scientists from the United States Food and Drug Administration, European Medicines Agency, Health Canada, and the Pharmaceuticals and Medical Devices Agency of Japan had monthly teleconferences from January 2014 through May 2015...
March 2017: Journal of Pediatric Gastroenterology and Nutrition
https://www.readbyqxmd.com/read/27234409/randomized-control-trial-of-human-recombinant-lactoferrin-a-substudy-reveals-effects-on-the-fecal-microbiome-of-very-low-birth-weight-infants
#14
RANDOMIZED CONTROLLED TRIAL
Michael P Sherman, Jan Sherman, Roxanne Arcinue, Victoria Niklas
UNLABELLED: The purpose of this study is to evaluate the effects of enteral lactoferrin on the fecal microbiome and contrast those influences with the neonatal intensive care unit (NICU) environment. We theorized that lactoferrin and the NICU habitat shape the fecal microbial composition of very preterm infants. Although functions attributed to lactoferrin include intestinal immune system development and emergence of a healthy gut microbiota, evidence is limited. Twenty-one very low birth weight (VLBW <1500 g) infants received twice-daily talactoferrin (TLf, a drug designation for recombinant human lactoferrin) or its excipient by gastric gavage from day 1-28 of life...
June 2016: Journal of Pediatrics
https://www.readbyqxmd.com/read/27031373/prebiotics-and-bioactive-milk-fractions-affect-gut-development-microbiota-and-neurotransmitter-expression-in-piglets
#15
Kirsten Berding, Mei Wang, Marcia H Monaco, Lindsey S Alexander, Austin T Mudd, Maciej Chichlowski, Rosaline V Waworuntu, Brian M Berg, Michael J Miller, Ryan N Dilger, Sharon M Donovan
OBJECTIVE: This study tested the hypothesis that the addition of prebiotics and 2 functional milk ingredients to infant formula would maintain normal growth and gut development, and modify microbiota composition and neurotransmitter gene expression in neonatal piglets. METHODS: Two-day-old male piglets (n = 24) were fed formula (CONT) or formula with polydextrose (1.2 g/100 g diet), galactooligosaccharides (3.5 g/100 g diet), bovine lactoferrin (0.3 g/100 g diet), and milk fat globule membrane-10 (2...
December 2016: Journal of Pediatric Gastroenterology and Nutrition
https://www.readbyqxmd.com/read/27022446/relevance-of-fecal-calprotectin-and-lactoferrin-in-the-post-operative-management-of-inflammatory-bowel-diseases
#16
REVIEW
Roberta Caccaro, Imerio Angriman, Renata D'Incà
The role of fecal lactoferrin and calprotectin has been extensively studied in many areas of inflammatory bowel disease (IBD) patients' management. The post-operative setting in both Crohn's disease (CD) and ulcerative colitis (UC) patients has been less investigated although few promising results come from small, cross-sectional studies. Therefore, the current post-operative management still requires endoscopy 6-12 mo after intestinal resection for CD in order to exclude endoscopic recurrence and plan the therapeutic strategy...
March 27, 2016: World Journal of Gastrointestinal Surgery
https://www.readbyqxmd.com/read/26982329/calprotectin-or-lactoferrin-do-they-help
#17
REVIEW
Emily K Wright
BACKGROUND: The diagnosis and monitoring of inflammatory bowel disease (IBD) has traditionally relied on clinical assessment, serum markers of inflammation and endoscopic examination. Fecal biomarkers such as calprotectin (FC) and lactoferrin (FL) are predominantly derived from neutrophils, are easily detectable in the feces and are now established as valuable markers of intestinal inflammation. In recent years, a 'treat to target' concept has emerged for the management of IBD. Adequate control of inflammation in IBD at a biochemical level is quickly becoming an important target in IBD management...
2016: Digestive Diseases
https://www.readbyqxmd.com/read/26975751/utility-of-surrogate-markers-for-the-prediction-of-relapses-in-inflammatory-bowel-diseases
#18
REVIEW
Jason Orlando Dimitri Musci, Jack Stephen Cornish, Jan Däbritz
Patients with diagnosed inflammatory bowel disease (IBD) will commonly experience a clinical relapse in spite of a prolonged therapy-induced period of clinical remission. The current methods of assessing subclinical levels of low-grade inflammation which predispose patients to relapse are not optimal when considering both cost and patient comfort. Over the past few decades, much investigation has discovered that proteins such as calprotectin that are released from inflammatory cells are capable of indicating disease activity...
June 2016: Journal of Gastroenterology
https://www.readbyqxmd.com/read/26913756/evaluation-of-intestinal-function-in-children-with-autism-and-gastrointestinal-symptoms
#19
Rafail I Kushak, Timothy M Buie, Katherine F Murray, David S Newburg, Ceng Chen, Eirini Nestoridi, Harland S Winter
OBJECTIVE: Alterations in intestinal function, often characterized as a "leaky gut," have been attributed to children who are on the autism spectrum. Disaccharidase activity, intestinal inflammation, and permeability were analyzed in 61 children with autism and 50 nonautistic individuals with gastrointestinal symptoms. METHODS: All patients had duodenal biopsies assayed for lactase, sucrase, maltase, and palatinase activity. Intestinal permeability was evaluated by rhamnose/lactulose test and measured by high-performance liquid chromatography-mass spectrometry...
May 2016: Journal of Pediatric Gastroenterology and Nutrition
https://www.readbyqxmd.com/read/26874351/faecal-lactoferrin-calprotectin-pmn-elastase-crp-and-white-blood-cell-count-as-indicators-for-mucosal-healing-and-clinical-course-of-disease-in-patients-with-mild-to-moderate-ulcerative-colitis-post-hoc-analysis-of-a-prospective-clinical-trial
#20
Jost Langhorst, James Boone, Romy Lauche, Andreas Rueffer, Gustav Dobos
OBJECTIVES: We evaluated the performance of blood and faecal biomarkers for differentiating between endoscopic inflammation and mucosal healing, and clinically active disease and sustained clinical remission, and determined the predictive value for a flare in patients with ulcerative colitis [UC]. METHODS: Clinical Activity Index [CAI], faecal lactoferrin [FLA], calprotectin [CAL], PMN-elastase [PMN-e], C-reactive protein [CRP], white blood cells [WBC], Endoscopic Index [EI], and UC-Disease Activity Index [DAI] were determined repeatedly during 12 months and at acute flares...
July 2016: Journal of Crohn's & Colitis
keyword
keyword
27774
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"